Answers are grounded in this paper and cite their sources.
Observational analysis found greater HRQoL in cystic fibrosis patients with CFTR enhancement, suggesting benefits for adolescents and adults over prior treatments.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Thorat et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: